Patients Deep Dive: Patients & Partnerships 2024 IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Oncology ASCO 2026: All about DNA damage response, with Luke Piggot Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
